Carey Ng

Insider Reports History

Location
Los Angeles, CA
Signature
/s/ Ilya Rachman as Attorney-In-Fact for Carey Ng
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carey Ng:

Company Role Class Num Shares Value Price $ Report Date Ownership
Immix Biopharma, Inc. Director Common Stock 1,025,221 $2,029,937 $1.98 20 Jun 2025 Indirect
Immix Biopharma, Inc. Director Common Stock 20,000 $39,600 $1.98 20 Jun 2025 Direct
Immix Biopharma, Inc. Director Stock Option (Right to Buy) 33,000 20 Jun 2025 Direct

Insider Reports Filed by Carey Ng

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IMMX Immix Biopharma, Inc. 20 Jun 2025 1 $0 4 Director 23 Jun 2025, 16:57
IMMX Immix Biopharma, Inc. 16 Aug 2024 1 +$18,600 4 Director 19 Aug 2024, 20:45
IMMX Immix Biopharma, Inc. 11 Jun 2024 1 $0 4 Director 21 Jun 2024, 17:45
IMMX Immix Biopharma, Inc. 15 May 2024 2 $0 4 Director 20 May 2024, 17:25
IMMX Immix Biopharma, Inc. 14 Sep 2023 1 +$25,760 4 Director 15 Sep 2023, 19:27
IMMX Immix Biopharma, Inc. 11 Aug 2023 1 $0 4 Director 14 Aug 2023, 17:15
IMMX Immix Biopharma, Inc. 14 Jul 2022 1 $0 4 Director 18 Jul 2022, 06:08
IMMX Immix Biopharma, Inc. 20 Dec 2021 3 +$225,188 4 Director 20 Dec 2021, 15:15
IMMX Immix Biopharma, Inc. 15 Dec 2021 0 $0 3 Director 15 Dec 2021, 19:59